Forensic and pharmaceutical research on the impact of drugs on the safety, life and health of road users within the organization of pharmaceutical business, drug technology, pharmaceutical and medical law in Ukraine

Authors

  • V.V. Shapovalov (Jr.) Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine; National Bar Association of Ukraine, Kyiv, Ukraine; Advocates company «Apotheosis», Kharkiv, Ukraine; Public organization «Association of medical and pharmaceutical law», Kharkiv, Ukraine, Ukraine, Ukraine
  • V.A. Shapovalova Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine; Public organization «Association of medical and pharmaceutical law», Kharkiv, Ukraine, Ukraine, Ukraine
  • V.V. Shapovalov National Bar Association of Ukraine, Kyiv, Ukraine; Advocates company «Apotheosis», Kharkiv, Ukraine; Public organization «Association of medical and pharmaceutical law», Kharkiv, Ukraine; Lviv Medical Institute LLC, Lviv, Ukraine, Ukraine, Ukraine

DOI:

https://doi.org/10.22141/2306-2436.10.4.2021.246355

Keywords:

forensic pharmacy, organization of pharmaceutical business, drug technology, pharmaceutical law, the impact of drugs on the safety, life and health of road users

Abstract

Background. Around the world, drug-related road traffic accidents are one of the leading causes of injury and death among road users. Traffic safety is a system that includes the following components: a person – a person's health condition – the use of dangerous drugs of different classification and legal groups – adverse drug reactions – a vehicle – a road. The share of road traffic accidents under the influence of drugs is more than 75 %, they are also the most socially dangerous, because they have grave consequences, cause irreparable harm to the health and death of the victims. The purpose of the study was to analyze the achievements of forensic and pharmaceutical researches in Ukraine on the impact of drugs on the safety, life and health of road users within the framework of the organization of pharmaceutical business, drug technology, pharmaceutical and medical law in a retrospective aspect. Materials and methods. The materials of the imperative research were legislative, regulatory and legal documents; materials of the formation of the scientific school of forensic pharmacy; scientific publications on the topic of the article; Internet resources, sources of scientific literature. To achieve the set goals, the methods of forensic and pharmaceutical, regulatory, documentary, bibliographic, comparative, historical and graphic analysis were used. Results. The experience of the countries of the world in the prophylaxis and prevention of road traffic accidents under the influence of drugs was analyzed. The causes and conditions for the occurrence and consequences of road traffic accidents are multifactorial in nature and are associated with the victims (driver - pedestrian), vehicle, road conditions, and the use of psychoactive drugs. A system of organizational, regulatory and preventive measures has been developed to provide first medical aid to victims of a road traffic accident. Shown that there is a need for scientifically grounded organizational and legal, clinical and pharmacological, forensic pharmaceutical and socio-economic studies on causal relationships between adverse reactions due to the use of drugs of various classification and legal groups, traffic safety and road traffic accidents. For the first time in Ukraine, a mathematical model was proposed to establish the effect of psychoactive drugs on the driver's condition when driving a vehicle, depending on the calculation of the stopping path of the car in accordance with the selected speed and a decrease in the driver's response. The structure of road traffic accidents under the influence of psychoactive drugs has been investigated. Conclusions. A classification of first-aid kits for providing first medical aid to victims of road traffic accidents was proposed, which made it possible to substantiate the need to improve them both in qualitative and quantitative composition, depending on the type of vehicle and the likelihood of an accident with serious consequences. Recommendations were proposed for providing information on the possibility of obtaining medical care and the signal-calling system on the roads, marking the packages of psychoactive drugs with a special mark in the form of a red triangle. The need for further forensic pharmaceutical research has been proven.

References

Безопасность лекарств. Экспресс-информация: Бюллетень. 2000. №1. 95с.

Бабаханян Р. Б., Бородавка В. К., Фисенко В. П. Отравления безрецептурными ненаркотическими анальгетиками. Безопасность лекарств. информация: Бюллетень. 2000. №1. С.39-41.

Bureau of Justice Statistics: Drugs, Crime, and the Justice System. Washington, DC: US Department of Justice, 1992. Vol.7. Р.158–173.

Левицький А. Ф., Заворицький Ю. Є., Дерех Л. З. Посібник для надання першої медичної допомоги при дорожньо-транспортних пригодах. Х.: НВП “Світлофор”, 1998. 103 с.

Папишев Н. М. Водителю о первой медицинской помощи. М.: ДОСААФ СССР, 1985. 63 с.

Научно-методическое обоснование комплексных судебных экспертиз: нарколого-фармацевтическое и психиатрическо-фармацевтическое / В. В. Шаповалов, И. М. Трахтенберг, В. А. Шаповалова, Н. М. Халин та ін. Архив психиатрии. 2002. №3(30). С.m214–215.

Мнушко З. М., Шуванова О. В. Аналіз інформаційних потреб фахівців, які працюють у галузі лікарського забезпечення. Ліки України. 2000. №12. С. 9–11.

О необходимости изучения вопросов правовой и судебной фармации в практической медицине и фармации при обороте лекарственных средств всех классификационно-правовых групп / В. В. Шаповалов, В. А. Шаповалова, Ю. И. Губский та ін. Фармакологічний вісник. 2000. №2. С. 39–42.

Оборот сильнодействующих и ядовитых веществ: история вопроса, терминология, состояние проблемы / И.М. Трахтенберг, В. А. Шаповалова, В. В. Шаповалов та ін. Современные проблемы токсикологии. 2002. №1. С. 4–7.

Толочко В. М., Пестун І. В., Лазарєв М. І. Моделювання асортименту лікарських засобів в аптечних закладах: метод. рек.–Х., 2001. 23 с.

Трахтенберг И.М. Книга о ядах и отравлениях. К.: Наук. думка, 2000. 366 с.

E5 (cpmp/ich/289/95). Ethnic Factors in the Acceptability of Foreign Clinical Data. Geneva, 1995. P. 100–289.

E9 (cpmp/ich/363/96). Statistical Principles for Clinical Trials. Geneva, 1996. P. 300–355.

Коноплянко В. И. Основы управления автомобилем и безопасность движения. М.: ДОСААФ СССР, 1987. 25 с.

Avorn J., Dreyer P., Soumerai S. Use of phychoactive medications and the quality of care in rest homes. N. Engl. J. Med. 1989. Vol.11. N. 320. Р. 227.

International Drug monitoring: the role of national centers: report of a WHO meeting. WHO Technical Report Series. 1972. 498 p.

M3 (cpmp/ich/386/95) Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals. New York. 1995. 386 p.

National Institute on Drug Abuse “Monitoring the Future Study” 1975–1992 (High School Seriors). Washington, DC: US Government Printing Office. 1993. 3597 р.

Кравченко П. И., Юзефович Д. Д. Безопасность дорожного движения. К.: Техника, 1989. 143 с.

Абросимов, О. С. Медикаментозне забезпечення заходів щодо попередження та ліквідації наслідків дорожньо-транспортних пригод: автореф. дис. на здобуття наук. ступеня канд. фармац. наук: спец. 15.00.01 «Технологія ліків та організація фармацевтичної справи» / О.С. Абросимов. Харків, 2004. 20 с.

Судебно-фармацевтическая оценка вопросов промышленной и транспортной безопасности при обороте психоактивных веществ / В. В. Шаповалов, В.А. Шаповалова, Н. М. Халин та ін. Экология 2002 – море и человек. Материалы Второй Всерос. науч. конф. с междунар. участием. Таганрог, 2002. №6(29). С. 223.

Судебно-фармацевтические аспекты обеспечения безопасности грузовых автомобильных перевозок лекарственных средств как условие исключения ущерба предприятию и окружающей среде / В. В. Шаповалов, В.А. Шаповалова, А. С. Абросимов та ін. Ліки України. 2001. №2(43). С. 25–27.

Шаповалов В. В., Абросимов А. С., Шаповалова В.А. Судебно-фармацевтический комментарий к статье 286 УК Украины “Нарушение правил безопасности дорожного движения или эксплуатации транспорта лицами, управляющими транспортными средствами” (в том числе под воздействием психоактивных веществ). Ліки України. 2003. №7–8(72-73) С. 60 –62.

Шаповалов В. В., Абросимов О. С., Шаповалова В. О. Причинно-наслідковий зв’язок між вживанням лікарських засобів та дорожньо-транспортними й іншими нещасними випадками. Ліки. 2002. №1–2. С. 115–119.

Токсикологічні та судово-фармацевтичні критерії щодо розмежування лікарських засобів до різних категорій / І. М. Трахтенберг, В. О. Шаповалова, О.П. Вікторов та ін. Фармація XXI століття: Тез. доп. Всеукр. наук.-практ. конф., 23–24 жовт. 2002 р. Х., 2002. С. 198–199.

Downloads

Published

2021-12-16

Issue

Vol. 10 No. 4 (2021)

Section

Pharmacy

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
  7. The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.